Senior execs have been working to spell out why secondaries mark-up practices make sense following public scepticism from peers.
3 min read · 28 May 2026
The real challenge appears operational rather than structural from a geographical standpoint, writes Winston & Strawn’s Yulia Makarova.
4 min read · 28 May 2026
Secondaries Investor’s latest CV deal log shows activity broadening across segments, transaction types and asset classes.
3 min read · 21 May 2026
The manager’s $1bn CFO created access for insurance investors that had lost the ability to back PE, while offering a compelling capital raising strategy for the firm itself.
4 min read · 21 May 2026
Lazard’s acquisition of Campbell Lutyens proves scale matters. While there’s room at the top for more players, success will come with a price tag.
3 min read · 14 May 2026
Apollo chief executive Marc Rowan’s comments this week point to a messy situation involving three of private markets’ hottest trends.
3 min read · 07 May 2026
While the US Department of Labor’s March proposal flagged CVs as an area of concern in 401(k) plans, it should not be taken as a signal to rule them out.
2 min read · 30 April 2026
Four debut strategies – including three focused on single-asset CV investments – ranked among the top 10 fundraises in Q1 2026. As LPs seek diversification, expect to see more of these funds drive figures.
3 min read · 23 April 2026
Secondaries Investor will launch its inaugural Global Market Survey next week. While there’s agreement on the market’s future growth, there are diverging views on alignment.
2 min read · 16 April 2026
Critics argue CVs entrench managers or delay inevitable exits. However, structured with transparency and fairness, these funds align interests rather than obscure them, writes AEA Investors’ and Painswick Capital’s John Garcia.
4 min read · 15 April 2026